… the relative vaccine effectiveness (rVE) of MF59-adjuvanted trivalent inactivated influenza
vaccine (… In this analysis of a large integrated EMR and medical claims database, aIIV3 was …

… a SAE of high fever in a recipient of a MF59 ® adjuvanted vaccine. A third … MF59 ® adjuvanted
influenza vaccines do not appear to offer a benefit over non-adjuvanted influenza vaccines…

… For the analysis, we used an integrated dataset comprising US primary and specialty care
data … This study used all available claims data for the analysis. The data sources have been …

… Comorbidity risk scores were ≥50 (indicating high risk) for 608 subjects (35%) in the per …
that it was not conducted against a non-adjuvanted quadrivalent vaccine in order to assess the …

… In this analysis of a large integrated EMR and medical claims database, aIIV3 was …
quadrivalent inactivated influenza vaccines and high-dose trivalent influenza vaccine in preventing …

… The high burden of … of an MF59®-adjuvanted trivalent influenza vaccine (aTIV) in adults
aged over 65 years in Argentina compared with the non-adjuvanted trivalent influenza vaccine (…

… This allowed an integrated analysis of a uniform data set with … by (pooled) GMTRs is
significantly larger than 1.0 in older … aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, …

… been assessed for use in influenza vaccines (7). Among … Using an unbiased, high-throughput
systems serology (30) … rational vaccine design efforts may benefit from a comprehensive …

… MF59-adjuvanted quadrivalent influenza vaccine (aIIV4) in healthy children and those at a
high risk of influenza-… A comprehensive medical history review was performed for all subjects …

… and older, particularly for those at high risk of severe influenza-associated complications, such
as … Immunogenicity and safety of an MF59®-adjuvanted and a non-adjuvanted inactivated …